Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.

Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, Sepúlveda N, Mathias da Fonseca DL, Baiocchi GC, Marques AHC, Kim M, Lange T, Plaça DR, Luebber F, Paulus FM, De Vito R, Jurisica I, Schulze-Forster K, Paul F, Bellmann-Strobl J, Rust R, Hoppmann U, Shoenfeld Y, Riemekasten G, Heidecke H, Cabral-Marques O, Scheibenbogen C

Open source

DOI: 10.3389/fimmu.2022.981532
Published: 2022
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.981532,
  title = {Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.},
  author = {Sotzny F and Filgueiras IS and Kedor C and Freitag H and Wittke K and Bauer S and Sepúlveda N and Mathias da Fonseca DL and Baiocchi GC and Marques AHC and Kim M and Lange T and Plaça DR and Luebber F and Paulus FM and De Vito R and Jurisica I and Schulze-Forster K and Paul F and Bellmann-Strobl J and Rust R and Hoppmann U and Shoenfeld Y and Riemekasten G and Heidecke H and Cabral-Marques O and Scheibenbogen C},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.981532},
  url = {https://doi.org/10.3389/fimmu.2022.981532}
}

RIS

TY  - JOUR
TI  - Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
AU  - Sotzny F
AU  - Filgueiras IS
AU  - Kedor C
AU  - Freitag H
AU  - Wittke K
AU  - Bauer S
AU  - Sepúlveda N
AU  - Mathias da Fonseca DL
AU  - Baiocchi GC
AU  - Marques AHC
AU  - Kim M
AU  - Lange T
AU  - Plaça DR
AU  - Luebber F
AU  - Paulus FM
AU  - De Vito R
AU  - Jurisica I
AU  - Schulze-Forster K
AU  - Paul F
AU  - Bellmann-Strobl J
AU  - Rust R
AU  - Hoppmann U
AU  - Shoenfeld Y
AU  - Riemekasten G
AU  - Heidecke H
AU  - Cabral-Marques O
AU  - Scheibenbogen C
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.981532
UR  - https://doi.org/10.3389/fimmu.2022.981532
ER  -

APA

F, S., IS, F., C, K., H, F., K, W., S, B., N, S., DL, M. D. F., GC, B., AHC, M., M, K., T, L., DR, P., F, L., FM, P., R, D. V., I, J., K, S., F, P., J, B., R, R., U, H., Y, S., G, R., H, H., O, C., & C, S. (2022). Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.981532

Source records

pubmed · retrieved 2026-09-25T05:51:07.282Z